Development of a novel conjugatable sunitinib analogue validated through in vitro and in vivo preclinical settings

Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
Mohamed A El MubarakGregory B Sivolapenko

Abstract

Sunitinib is an oral FDA/EMEA approved multi-targeted tyrosine kinase inhibitor. It possesses anti-angiogenic and antitumor activity against a variety of advanced solid tumors. However, its chemical core does not allow a potential linkage to tumor-homing elements that could eventually enhance its potency. Therefore, a novel linkable sunitinib derivative, designated SB1, was rationally designed and synthesized. The pharmaceutical profile of SB1 was explored both in vitro and in vivo. Mass spectrometry and NMR spectroscopy were utilized for characterization, while MTT assays and LC-MS/MS validated protocols were used to explore its antiproliferative effect and stability, respectively. Cytotoxicity evaluation in three glioma cells showed that SB1 preserved the antiproliferative effect of sunitinib. SB1 was stable in vitro after 24 h incubation in mouse plasma, while both agents exhibited bioequivalent pharmacokinetic characteristics after i.v. administration in Balb/c mice. To evaluate the levels of SB1 in mouse plasma, a novel analytical method was developed and validated in accordance to the US FDA and the EU EMA guidelines. We formulated a novel linkable sunitinib analog exhibiting similar antiproliferative and apoptotic proper...Continue Reading

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Related Papers

The Annals of Pharmacotherapy
Fariba NavidSharyn Baker
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Carlo L BelloLee Rosen
Cancer Chemotherapy and Pharmacology
Kenneth KolinskyBrian Higgins
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Sandrine FaivreEric Raymond
© 2022 Meta ULC. All rights reserved